Researchers forced to scrap original studies as NIH rethinks grants not in ‘alignment’ with administration’s priorities

The process has injected uncertainty, confusion and woe into scientific grant-making at the NIH over the past two years. Renegotiations force program officers, who typically take pride in shepherding critical research, to flag grants on topics the Trump administration disfavors. Even as they do so, they must guess what the “no-no” words are: NIH director Jay Bhattacharya has repeatedly denied a list of banned words exists.

Data shared exclusively with the Guardian shows re-negotiations surged in the first two years of the Trump administration. In 2023, only 154 of more than 40,000 grants up for renewal changed their titles, abstracts or public health statements: 0.4% of all grants, according to an analysis by Grant Witness, an independent group that tracks canceled government grants.

Those changes increased 21-fold during the Trump administration. In 2025, 8.6% of all grants changed year-to-year, or more than 3,401 of the more than 39,000 grant continuations awarded by NIH. In 2026, 8.5% of all continuing grants changed, or 3,006 of the agency’s nearly 35,500 grants, according to an analysis by Grant Witness.